Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
Ridwanur RahmanVishal GoyalRashidul HaqueKazi JamilAbul FaizRasheda SamadSally EllisManica BalasegaramMargriet den BoerSuman RijalNathalie Strub-WourgaftFabiana AlvesJorge AlvarBhawna SharmaPublished in: PLoS neglected tropical diseases (2017)
ClinicalTrials.gov NCT01122771.
Keyphrases